Mikart and Nano PharmaSolutions Reveal Promising NT-301 Trial Data and Expand Manufacturing Capabilities Mikart and Nano PharmaSolutions announced positive interim results from the NT-301 Phase 1 trial, focusing on advancing manufacturing capabilities for Parkinson's treatment.

Mikart and Nano PharmaSolutions Reveal Promising NT-301 Trial Data and Expand Manufacturing Capabilities #USA #Atlanta #Mikart #NanoTransformer #Nano_PharmaSolutions